Chuhan Chung Selected Research

Fenofibrate (CiL)

1/2023	Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat.
1/2023	Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: prevention by fenofibrate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chuhan Chung Research Topics

Disease

18	Fibrosis (Cirrhosis) 03/2023 - 03/2013
10	Non-alcoholic Fatty Liver Disease 01/2023 - 11/2018
9	Liver Cirrhosis (Hepatic Cirrhosis) 03/2023 - 04/2011
6	Neoplasms (Cancer) 10/2016 - 09/2006
4	Sclerosing Cholangitis 03/2023 - 01/2019
4	type 6 Osteogenesis imperfecta 01/2016 - 11/2013
3	Cholestasis 03/2023 - 01/2019
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2019
3	Pruritus (Itching) 01/2023 - 01/2020
3	Liver Diseases (Liver Disease) 01/2023 - 11/2002
3	Inflammation (Inflammations) 11/2022 - 05/2016
3	Carcinoma in Situ 10/2016 - 05/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 05/2016 - 05/2011
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2014 - 12/2012
2	Insulin Resistance 01/2022 - 12/2012
2	Osteogenesis Imperfecta (Lobstein Disease) 01/2016 - 11/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2015 - 01/2008
2	Hepatic Encephalopathy 09/2003 - 01/2003
2	Brain Edema (Cerebral Edema) 08/2003 - 08/2003
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2023
1	Hypertriglyceridemia 01/2023
1	Alcoholic Fatty Liver 10/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2022
1	Portal Hypertension 12/2021
1	Disease Progression 01/2021
1	Cholangitis 02/2020
1	Fatty Liver 01/2020
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2017
1	Cicatrix (Scar) 07/2016
1	Carcinogenesis 05/2016
1	Multiple Fractures 12/2015
1	Bone Diseases (Bone Disease) 12/2015
1	Rare Diseases (Rare Disease) 12/2015
1	Hyperglycemia 04/2014
1	Diabetes Mellitus 12/2012
1	Hypertrophy 10/2012
1	Pancreatitis 12/2011
1	Adenocarcinoma 05/2011

Drug/Important Bio-Agent (IBA)

11	pigment epithelium-derived factorIBA 10/2016 - 09/2006
8	Proteins (Proteins, Gene)FDA Link 01/2017 - 11/2013
7	cilofexorIBA 03/2023 - 01/2019
6	Bile Acids and Salts (Bile Acids)IBA 03/2023 - 01/2019
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2018
6	CollagenIBA 01/2022 - 05/2016
5	firsocostatIBA 01/2023 - 11/2018
4	Insulin (Novolin)FDA Link 10/2022 - 12/2012
4	CateninsIBA 10/2016 - 11/2014
4	AmmoniaIBA 12/2004 - 01/2003
3	selonsertibIBA 01/2023 - 01/2021
3	Acetyl-CoA CarboxylaseIBA 01/2023 - 12/2018
3	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2022
3	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2023 - 01/2019
3	Alanine Transaminase (SGPT)IBA 01/2022 - 02/2020
2	simtuzumabIBA 01/2023 - 01/2022
2	Fenofibrate (CiL)FDA LinkGeneric 01/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2022 - 01/2008
2	BilirubinIBA 12/2021 - 01/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2021 - 01/2021
2	Alkaline PhosphataseIBA 01/2021 - 02/2020
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 02/2020 - 01/2020
2	CytokinesIBA 05/2016 - 12/2011
2	CeruletideIBA 05/2016 - 12/2011
2	Adenosine Triphosphatases (ATPase)IBA 11/2014 - 05/2011
2	Matrix Metalloproteinases (MMPs)IBA 10/2012 - 05/2011
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	Apolipoproteins B (ApoB)IBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 10/2022
1	glucokinase regulatory proteinIBA 10/2022
1	Oxidants (Oxidizing Agents)IBA 10/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	O(4)-methylthymidine triphosphateIBA 01/2022
1	PalmitatesIBA 01/2022
1	VLDL LipoproteinsIBA 01/2022
1	Deuterium Oxide (Heavy Water)IBA 01/2022
1	4-(3-chlorophenylsulfanyl)piperidineIBA 12/2021
1	Drug CombinationsIBA 01/2021
1	nasIBA 01/2021
1	Keratin-18 (Keratin 18)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Tissue Inhibitor of Metalloproteinase-1IBA 11/2018
1	Protons (Proton)IBA 11/2018
1	Glycoproteins (Glycoprotein)IBA 10/2016
1	Wnt3A ProteinIBA 10/2016
1	LigandsIBA 10/2016
1	IntegrinsIBA 07/2016
1	Peptides (Polypeptides)IBA 01/2015
1	Low Density Lipoprotein Receptor-Related Protein-6IBA 01/2015
1	MineralsIBA 11/2013
1	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2013
1	Glucose (Dextrose)FDA LinkGeneric 12/2012
1	SerpinsIBA 10/2012
1	Ethanol (Ethyl Alcohol)IBA 12/2011
1	CortactinIBA 05/2011
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 05/2011

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2021
2	Transplantation 02/2020 - 11/2002
2	Surgical Portacaval Shunt (Portacaval Anastomosis) 12/2004 - 08/2003
1	Liver Transplantation 01/2023